Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients

doi:10.4240/wjgs.v14.i6.580

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4408)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

200

WORD

HTML

2071

Figures (1-5)

188

Tables (1-3)

196

Sum=2739

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

393

Download

1276

Sum=1669

Jun 27, 2022 (publication date) through Sep 4, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jun 27, 2022; 14(6): 580-593
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.580

Table 1 Prognostic analysis of clinical characteristics in patients with gastric cancer

Clinical variable	n	Univariate analysis		Multivariate analysis
Clinical variable	312	HR (95%CI)	P value	HR (95%CI)	P value
Age (yr)	62 (54-68)	1.046 (1.015-1.077)	0.003	1.049(1.017-1.081)	0.002
Sex (male/female)	225/87	0.715 (0.400-1.280)	0.259
BMI (kg/m²)	21.55 (19.53-23.55)	0.983 (0.911-1.062)	0.670
Smoking (yes/no)	64/248	0.442 (0.189-1.034)	0.060
Drinking (yes/no)	49/263	1.316 (0.641-2.701)	0.454
CEA (ng/mL)	2.94 (1.85-5.29)	1.006 (1.003-1.009)	0.000
CA19-9 (U/mL)	13.26 (7.36-23.70)	1.001 (1.000-1.002)	0.003
CA125 (U/mL)	8.50 (5.90-13.80)	1.008 (1.000-1.016)	0.049
CA72-4 (IU/mL)	1.81 (1.17-4.46)	1.004 (0.990-1.018)	0.57
HAR	3.18 (2.68-3.44)	0.425 (0.278-0.650)	0.000	0.466 (0.301-0.720)	0.001
PHR	1.86 (1.40-2.58)	1.371 (1.194-1.575)	0.000
PLR	157.74 (114.06-211.23)	1.003 (1.001-1.006)	0.004
PAR	5.75 (4.51-7.48)	1.184 (1.088-1.288)	0.000
FLR	2.05 (1.49-2.89)	1.171 (1.018-1.347)	0.028
AFR	13.16 (10.36-16.85)	0.970 (0.912-1.033)	0.344
HFR	42.52 ± 17.83	0.974 (0.955-0.993)	0.007
PFR	77.41 (57.84-101.46)	1.005 (0.998-1.012)	0.135
NLR	2.47 (1.76-3.59)	1.100 (0.974-1.242)	0.124
ALR	26.25 (22.16-35.08)	1.008 (0.986-1.030)	0.489
Tumor size (cm)	4.0 (2.5-5.5)	1.167 (1.079-1.262)	0.000
Vascular infiltration (present/absent)	168/144	3.230 (1.695-6.153)	0.000
Nerve infiltration (present/absent)	149/163	2.974 (1.651-5.359)	0.000
Histological grade (G1/G2/G3)	6/120/186	0.920 (0.553-1.530)	0.748
Stage (Ⅰ/Ⅱ/Ⅲ)	88/75/149	4.154 (2.291-7.531)	0.000	4.112 (2.225-7.602)	0.000
Survival status (death/survival)	53/259
Follow-up time (d)	531 (440-691)

BMI: Body mass index; PHR: Platelet to hemoglobin ratio; PLR: Platelet to lymphocyte ratio; PAR: Platelet to albumin ratio; FLR: Fibrinogen to lymphocyte ratio; AFR: Albumin to fibrinogen ratio; HFR: Hemoglobin to fibrinogen ratio; PFR: Platelet to fibrinogen ratio; NLR: Neutrophil to lymphocyte ratio; ALR: Albumin to lymphocyte ratio. HR: Hazard ratio; CI: Confidence interval; HAR: Hemoglobin to albumin ratio.

Citation: Hu CG, Hu BE, Zhu JF, Zhu ZM, Huang C. Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients . World J Gastrointest Surg 2022; 14(6): 580-593
URL: https://www.wjgnet.com/1948-9366/full/v14/i6/580.htm
DOI: https://dx.doi.org/10.4240/wjgs.v14.i6.580